Insider Trading & Ownership - Deliargyris Efthymios

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Deliargyris Efthymios
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-12-13
Purchase
2023-12-15
4:34 pm
Cytosorbents CorpCTSODeliargyris Efthymios
Chief Medical Officer
22,557$1.33$30,001356,327
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-04-02
Option Award
2024-04-04
9:47 pm
N/A
2034-04-02
Cytosorbents CorpCTSODeliargyris Efthymios
Chief Medical Officer
147,000$0495,433
(Direct)
View
2024-03-29
Option Award
2024-04-02
9:32 pm
N/A
2034-03-29
Cytosorbents CorpCTSODeliargyris Efthymios
Chief Medical Officer
47,088$047,088
(Direct)
View
2023-07-07
Option Award
2023-07-11
8:30 pm
N/A
2033-07-07
Cytosorbents CorpCTSODeliargyris Efthymios
Chief Medical Officer
173,000$0449,648
(Direct)
View
2022-08-10
Option Award
2022-08-12
6:49 pm
N/A
2032-08-10
Cytosorbents CorpCTSODeliargyris Efthymios
Chief Medical Officer
481,000$0657,384
(Direct)
View
2021-04-12
Option Award
2021-04-14
9:14 pm
N/A
2031-04-12
Cytosorbents CorpCTSODeliargyris Efthymios
Chief Medical Officer
63,250$0246,250
(Direct)
View
2021-04-12
Option Award
2021-04-14
9:14 pm
N/A
N/A
Cytosorbents CorpCTSODeliargyris Efthymios
Chief Medical Officer
40,000$8.99246,250
(Direct)
View
2020-04-12
Option Award
2020-05-05
4:16 pm
N/A
2030-04-12
Cytosorbents CorpCTSODeliargyris Efthymios
Chief Medical Officer
225,500$0225,500
(Direct)
View
2020-03-20
Option Award
2020-03-24
8:50 pm
N/A
2030-03-20
PLx Pharma Inc.PLXPDeliargyris Efthymios
Chief Medical Officer
60,000$060,000
(Direct)
View